Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0000899243-20-026662

Director bought 10,000 shares at an average $15.15 ($151,500)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gray Cameron Director 2020-09-29 Purchase +5,000 $15.00 $75,000 672,500 D: show line 1 in the form
Gray Cameron Director 2020-09-30 Purchase +5,000 $15.30 $76,500 677,500 D: show line 2 in the form
Open-market purchases · 10,000 sh · avg $15.15 · $151,500
Loading xslF345X03/doc4.xml…